MORSE HTA Strategic Advice

“Do you need an expert opinion on your HTA submission or assistance with critical decision making and communications with HTA agencies? “

FEEDBACK ON THIS SERVICE

"We recently used the ‘MORSE HTA strategic advice’ service and found it extremely useful. If you are stuck or need any advice on your HTA strategy I would highly recommend this service. The MORSE team provides a thorough analysis, unique insights and detailed feedback that will really help strengthen your overall HTA strategy!"

– Patient Access Senior Manager

Toronto-based pharma company

"MORSE’s HTA assessment was key in guiding the decision on whether, and/or how, new or previously reviewed evidence could be positioned in a resubmission to achieve a positive recommendation from CADTH. MORSE’s thorough assessment brought a fresh view to our internal discussions and was used to support our access strategy for this product."

– Senior Manager, Market Access Strategy

Toronto-based pharma company

MORSE Consulting Inc. is pleased to announce its newest service offering – from the pre-submission to post-review phase of HTA, MORSE’s HTA expert Anita Carrie is well-equipped to provide advice with her 10+ years of experience leading or conducting the review of over 100 HTA submissions at CADTH.

If your team has specific needs related to any of our Health Technology Assessment (HTA) services, MORSE has the flexibility to customize its service offerings to meet those needs.

HTA Phase	Pre-Submission	Review		Post-Review
Client Need	Assess the strength of evidence in submission dossier to achieve desired HTA outcome	Identify major issues to address in CADTH reports and optimize success	Gain insights into the likelihood of success at reconsideration to balance risk and benefit	Gain insights into the likelihood of success at resubmission with newly generated evidence
What We Offer	Thorough review and critical appraisal of submission dossier	Advice and assistance in responding to CADTH reports	Advice and assistance with requests for reconsideration	Advice regarding potential for and approach to resubmission
Value/Outcome	Strengthen submission to optimize HTA success.	Mitigate issues and develop strategies for a more favorable recommendation.		Assess the viability of a successful resubmission to HTA.

MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.

New MORSE HTA Strategic Advice

MORSE HTA Strategic Advice

“Do you need an expert opinion on your HTA submission or assistance with critical decision making and communications with HTA agencies? “

FEEDBACK ON THIS SERVICE

HTA Phase

Pre-Submission

Review

Post-Review

Client Need

Assess the strength of evidence in submission dossier to achieve desired HTA outcome

Identify major issues to address in CADTH reports and optimize success

Gain insights into the likelihood of success at reconsideration to balance risk and benefit

Gain insights into the likelihood of success at resubmission with newly generated evidence

What We Offer

Thorough review and critical appraisal of submission dossier

Advice and assistance in responding to CADTH reports

Advice and assistance with requests for reconsideration

Advice regarding potential for and approach to resubmission

Value/Outcome

Strengthen submission to optimize HTA success.

Mitigate issues and develop strategies for a more favorable recommendation.

Assess the viability of a successful resubmission to HTA.

You're viewing an older edition